AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy - Top-Institutions - MDSpire

AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy

  • By

  • Benedette Cuffari

  • July 9, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University Hospital Southampton
    University Hospital Southampton

    Southampton, England

    Key Differentiators

    • Nuclear Medicine

  • #2

    GARNET trial
    GARNET trial

    Multinational, N/A

    Key Differentiators

    • Clinical Trials

  • #3

    Center for Personalized Cancer Therapy at Moores Cancer Center, University of California, San Diego
    Center for Personalized Cancer Therapy at Moores Cancer Center, University of California, San Diego

    La Jolla, California

    Key Differentiators

    • Personalized Medicine

  • #4

    Weill Cornell Medicine
    Weill Cornell Medicine

    New York, New York

    Key Differentiators

    • Radiology

  • #5

    Emory University School of Medicine
    Emory University School of Medicine

    Atlanta, Georgia

    Key Differentiators

    • Medicine

Original Source(s)

AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy

  • by Benedette Cuffari

  • July 9, 2026

Related Content

Berberine restrains the expansion of colorectal cancer organoids by blocking cell cycle progression and reducing lipid synthesis

KRAS G12C inhibitors in KRASG12C-mutated solid tumors: an immunologically informed systematic review and reconstructed individual patient data meta-analysis

Small intestinal metastasis of triple-negative breast cancer mimicking lymphoma: imaging findings and case report